Chapter 1. PREDICTIVE DIAGNOSTICS MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. PREDICTIVE DIAGNOSTICS MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights  

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. PREDICTIVE DIAGNOSTICS MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. PREDICTIVE DIAGNOSTICS MARK ET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. PREDICTIVE DIAGNOSTICS MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. PREDICTIVE DIAGNOSTICS MARKET – By Type

6.1. Presymptomatic

6.2. Predispositional

Chapter 7. PREDICTIVE DIAGNOSTICS MARKET – By Test

7.1. PCR based

7.2. NGS based

Chapter 8. PREDICTIVE DIAGNOSTICS MARKET – By  Indication

8.1. Cancer

8.2. Neurological Disorder

8.3. Metabolic Disorder

8.4. Musculoskeletal Disease

8.5. Others

Chapter 9. PREDICTIVE DIAGNOSTICS MARKET – By End User

9.1 Diagnostics

9.2. Genetic Laboratories and Clinics

9.3. Research and Academic Institutes

Chapter 10. PREDICTIVE DIAGNOSTICS MARKET – By Region

10.1. North America

10.2. Europe

10.3.The Asia Pacific

10.4.Latin America

10.5. Middle-East and Africa

Chapter 11. PREDICTIVE DIAGNOSTICS MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

11.1. Company 1

11.2. Company 2

11.3. Company 3

11.4. Company 4

11.5. Company 5

11.6. Company 6

11.7. Company 7

11.8. Company 8

11.9. Company 9

11.10. Company  10